Tuesday, April 23, 2024 4/23/2024

Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System

Award Number: P20GM130459
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Project Summary - Overall This Phase II Center of Biomedical Research Excellence (COBRE) proposal aims to sustain and enhance an interdisciplinary research Center within the University of Nevada, Reno (UNR) focused on fundamental molecular and cellular signal transduction mechanisms within the cardiovascular system. Our COBRE is unique, as there are no existing centers or institutes with a focus on basic cardiovascular research within the State of Nevada. The unifying scientific theme of the COBRE is the discovery and characterization of novel molecular and cellular signaling mechanisms that regulate the cardiovascular system in health and disease. This research mission is significant because cardiovascular diseases remain the leading causes of death and disability in the US and much of the world. COBRE-sponsored research programs develop deep insight into the basic molecular and cellular signaling mechanisms that regulate cardiovascular function, thereby accelerating the rate of discovery of new treatments for common cardiovascular diseases and ultimately improving human health. The primary function of Phase II is to provide mentoring and support for the COBRE’s Research Project Leaders (RPLs), a group of three promising early-stage investigators, with the goal of developing them into fully established research scientists funded by independent Research Program Grants (RPGs), such as an NIH R01 or equivalent. The COBRE will continue to improve the research infrastructure at UNR by maintaining and enhancing two research cores—the Transgenic Animal Genotyping and Phenotyping Core (Core B) and the High Spatial and Temporal Resolution Imaging Core (Core C)—to serve the needs of the RPLs and the wider research community. Phase II of the COBRE will lay the groundwork for the long-term sustainability of the Center by increasing the number of RPG-supported investigators within cardiovascular theme at UNR and by promoting collaborations among these investigators to stimulate the development of new multi-PI R01s and Program Project Grants. Dr. Scott Earley, Professor of Pharmacology, is the Principal Investigator and COBRE Director. Dr. Earley is an accomplished investigator with an established track record of NIH funding and publication in high-quality journals. Additional scientific leadership will be provided by a group of outstanding established investigators with common interests in ion channels, localized Ca2+ signaling, intracellular signal transduction pathways, transgenic animal models, endothelial cell function, epigenetics, novel cell surface receptors, neuronal cardiovascular control, localized signaling domains, and excitation/contraction coupling in cardiomyocytes and smooth muscle cells. Successful completion of the objectives of Phase II will maintain and enhance the Nevada COBRE in and Cellular Signal Transduction in the Cardiovascular System as a sustainable multidisciplinary Molecular research Center with a critical mass of investigators working within this thematic focus.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $2,202,799 )
2024	2024	BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER ED	1664 N VIRGINIA ST # 285	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	001	6	3/5/2024	COMPETING CONTINUATION	$2,202,799
2024	2023	BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER ED	1664 N VIRGINIA ST # 285	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	000	5	3/4/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,202,799

Issue Date FY: 2023 ( Subtotal = $2,158,487 )
2023	2023	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	000	5	1/19/2023	NON-COMPETING CONTINUATION	$1,942,638
2023	2023	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	001	5	2/15/2023	NON-COMPETING CONTINUATION	$215,849
2023	2023	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	002	5	4/5/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,158,487

Issue Date FY: 2022 ( Subtotal = $2,325,987 )
2022	2022	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	004	4	8/17/2022	NON-COMPETING CONTINUATION	$0
2022	2022	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	002	4	6/20/2022	SUPPLEMENT FOR EXPANSION	$167,500
2022	2022	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	000	4	1/31/2022	NON-COMPETING CONTINUATION	$1,942,635
2022	2022	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	001	4	5/26/2022	NON-COMPETING CONTINUATION	$215,852
2022	2022	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	003	4	7/29/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,325,987

Issue Date FY: 2021 ( Subtotal = $2,408,487 )
2021	2021	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	000	3	1/22/2021	NON-COMPETING CONTINUATION	$1,942,637
2021	2021	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	004	3	9/21/2021	NON-COMPETING CONTINUATION	$0
2021	2021	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	003	3	9/1/2021	SUPPLEMENT FOR EXPANSION	$250,000
2021	2021	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	002	3	2/8/2021	NON-COMPETING CONTINUATION	$0
2021	2021	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	001	3	2/3/2021	NON-COMPETING CONTINUATION	$215,850
														Subtotal = $2,408,487

Issue Date FY: 2020 ( Subtotal = $2,158,487 )
2020	2020	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	000	2	12/27/2019	NON-COMPETING CONTINUATION	$1,942,637
2020	2020	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	001	2	3/16/2020	NON-COMPETING CONTINUATION	$215,850
														Subtotal = $2,158,487

Issue Date FY: 2019 ( Subtotal = $2,393,747 )
2019	2019	NEVADA SYSTEM OF HIGHER EDUCATION	1664 N VIRGINIA ST	RENO	NV	89557	WASHOE	USA	Biomedical Research and Research Training	000	1	12/21/2018	NEW	$2,393,747
														Subtotal = $2,393,747

Grand Total All Awards = $13,647,994

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System

Award Number: P20GM130459

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer